Tokyo, Dec 24, 2009 (JCN Newswire) - A New Drug Application for the pancreatic enzyme replacement therapy agent for pancreatic exocrine insufficiency, SA-001 (API name: Pancrelipase) that Solvay Seiyaku K. K. co-developed with Eisai Co., Ltd. was submitted by Solvay Seiyaku on December 22, 2009 in Japan.
